CPH
Physician Daily · Monday, August 24, 2026
Newsletters Sign in ON AIR
CrosspointHealthNEWS + REFERENCE LIBRARY
Diagnosis Sheet Trauma- and Stressor-Related Disorders DSM-5-TR 309.81 | ICD-10-CM F43.10

Posttraumatic Stress Disorder

Persistent intrusion, avoidance, negative alterations in cognition and mood, and hyperarousal lasting beyond one month after trauma.

Lifetime prevalence~6.8% (US adults)
Typical onsetWithin 3 months of trauma
Sex ratio~2:1 female:male
Course~50% remit within 1 year

Clinical picture

  • Intrusions are involuntary and sensory rather than deliberate recall: flashbacks, nightmares, and cue-triggered distress with autonomic surge.
  • Avoidance of reminders progressively narrows life domains, and patients present for insomnia, pain, or substance use rather than for trauma.
  • Negative cognitions center on self-blame, permanent damage, and a foreshortened future, accompanied by persistent shame, guilt, and anger.
  • Hyperarousal includes hypervigilance, exaggerated startle, irritability or aggression, reckless behavior, and fragmented sleep.
  • Depersonalization or derealization mark a dissociative subtype associated with early, repeated interpersonal trauma and worse function.
  • Children may show trauma reenactment in play, frightening dreams without recognizable content, and developmental regression rather than verbal report.

Criteria snapshot

  • Requires exposure to actual or threatened death, serious injury, or sexual violence, directly, as a witness, by learning of it, or through repeated occupational exposure.
  • Symptoms span four clusters: at least one intrusion, one avoidance, two negative alterations in cognition and mood, and two arousal or reactivity symptoms.
  • Duration must exceed one month with clinically significant distress or impairment, and symptoms cannot be attributable to substances or medical illness.
  • Specify with dissociative symptoms, or with delayed expression when full criteria are not met until at least six months after the event.
  • A separate developmental criteria set applies to children age six and younger, requiring fewer symptoms and using behavioral anchors.

Neurobiology

  • Amygdala hyperreactivity with reduced ventromedial prefrontal inhibition impairs fear extinction learning and, critically, extinction recall.
  • Hippocampal volume reduction correlates with symptom severity and degrades contextual discrimination between genuinely safe and dangerous cues.
  • The HPA axis shows low cortisol with enhanced glucocorticoid receptor sensitivity and exaggerated negative feedback, opposite the pattern in depression.
  • Noradrenergic hyperactivity originating in the locus coeruleus underlies startle and nightmares and provides the rationale for prazosin.
  • Twin heritability is roughly 30-40%, and FKBP5 variants interact with childhood adversity to raise risk after adult trauma exposure.
  • Chronic PTSD carries elevated rates of cardiovascular disease, metabolic syndrome, autoimmune illness, and later dementia.

Psychology

  • Two-factor learning theory: fear is classically conditioned to trauma cues, then avoidance is negatively reinforced and blocks natural extinction.
  • Emotional processing theory holds that a fragmented fear structure must be activated and then met with corrective information to change.
  • The cognitive model emphasizes stuck points, distorted appraisals of ongoing danger, self-blame, and beliefs assimilated to preserve prior worldview.
  • Peritraumatic dissociation, prior trauma, low social support, and poor post-trauma support predict chronicity more strongly than event severity.
  • Moral injury, institutional or caregiver betrayal, and guilt often respond better to cognitive approaches than to exposure-only protocols.

Differential & comorbidity

  • Acute stress disorder covers 3 days to 1 month; adjustment disorder covers non-Criterion A stressors or subthreshold responses to trauma.
  • Differentiate from panic disorder, OCD intrusions, traumatic brain injury sequelae, and psychotic disorders with true hallucinations.
  • Comorbidity is the rule: major depression in about half of patients, alcohol or substance use disorders in 30-50%, and frequent chronic pain.
  • Suicide risk is elevated roughly two- to threefold, so assess ideation, means access, and reckless behavior at every clinical contact.
  • Screen veterans for TBI, obstructive sleep apnea, and hearing loss, since untreated sleep pathology blunts response to trauma therapy.

Pharmacologic treatment

  • Sertraline 50-200 mg/day and paroxetine 20-60 mg/day are FDA-approved, and venlafaxine XR 75-225 mg/day has comparable evidence.
  • Allow 8-12 weeks at an adequate dose; effect sizes are modest and VA/DoD guidance prefers trauma-focused psychotherapy first-line.
  • Prazosin 1-15 mg at bedtime reduces trauma-related nightmares in many patients; titrate slowly and monitor orthostatic hypotension.
  • Avoid benzodiazepines, which impair extinction learning, worsen long-term outcomes, and carry high dependence risk in this population.
  • Do not use antipsychotics routinely; adjunctive risperidone showed no benefit over placebo in the large VA cooperative study.

Psychotherapy

  • Trauma-focused therapies are first-line: prolonged exposure, cognitive processing therapy, and EMDR, each across 8-16 sessions.
  • Cognitive processing therapy addresses stuck points over 12 sessions and can be delivered with or without a written trauma account.
  • Prolonged exposure combines in vivo and imaginal exposure with post-exposure processing across 8-15 sessions of 60-90 minutes.
  • Written exposure therapy achieves noninferior outcomes in only five sessions and produces markedly lower dropout rates.
  • Trauma-focused CBT is the standard for children and adolescents, running 12-16 sessions with structured caregiver participation.

Adjunct options

  • Administer the PCL-5 at baseline and every 2-4 weeks; a 10-20 point decrease indicates clinically meaningful improvement.
  • Treat sleep directly with CBT-I and imagery rehearsal therapy, since residual insomnia and nightmares predict relapse.
  • Concurrent treatment of substance use disorder alongside trauma-focused therapy outperforms requiring abstinence before starting.
  • Aerobic exercise, trauma-sensitive yoga, and mindfulness lower hyperarousal but do not substitute for trauma-focused psychotherapy.
  • MDMA-assisted therapy is not FDA-approved; the 2024 application drew a complete response letter and further trials are ongoing.

Clinical pearls

  • Benzodiazepines block extinction learning; they make PTSD worse, not better.
  • Prazosin at bedtime for nightmares; titrate slowly and check orthostatic vitals.
  • Trauma-focused psychotherapy beats medication; lead with PE, CPT, or EMDR.

References

  • American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787
  • American Psychological Association. (2017). Clinical practice guideline for the treatment of posttraumatic stress disorder (PTSD) in adults. https://www.apa.org/ptsd-guideline
  • National Institute for Health and Care Excellence. (2018). Post-traumatic stress disorder (NICE guideline NG116). https://www.nice.org.uk/guidance/ng116
  • National Institute of Mental Health. (n.d.). Post-traumatic stress disorder. U.S. Department of Health and Human Services. https://www.nimh.nih.gov/health/topics/post-traumatic-stress-disorder-ptsd
  • Sadock, B. J., Sadock, V. A., & Ruiz, P. (2021). Kaplan & Sadock's synopsis of psychiatry (12th ed.). Wolters Kluwer.
  • Stahl, S. M. (2021). Stahl's essential psychopharmacology (5th ed.). Cambridge University Press.
  • U.S. Department of Veterans Affairs & U.S. Department of Defense. (2023). VA/DoD clinical practice guideline for the management of posttraumatic stress disorder and acute stress disorder (Version 4.0). https://www.healthquality.va.gov/guidelines/MH/ptsd/